iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Down 37.3% in February

iCoreConnect Inc. (NASDAQ:ICCT) saw a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 46,300 shares, a decline of 37.3% from the January 31st total of 73,900 shares. Based on an average trading volume of 620,500 shares, the days-to-cover ratio is currently 0.1 days. Approximately 3.3% of the company’s stock are sold short.

Hedge Funds Weigh In On iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Virtu Financial LLC purchased a new position in shares of iCoreConnect Inc. (NASDAQ:ICCT) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned about 1.04% of iCoreConnect at the end of the most recent reporting period. 13.42% of the stock is currently owned by institutional investors.

iCoreConnect Stock Down 11.9 %

Shares of NASDAQ:ICCT traded down $0.09 during trading hours on Monday, reaching $0.69. The stock had a trading volume of 318,221 shares, compared to its average volume of 304,091. iCoreConnect has a 1 year low of $0.67 and a 1 year high of $35.80. The firm’s 50 day moving average is $2.31 and its 200-day moving average is $5.05. The stock has a market capitalization of $1.43 million, a price-to-earnings ratio of -0.01 and a beta of 0.87. The company has a debt-to-equity ratio of 7.93, a quick ratio of 0.11 and a current ratio of 0.11.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.